Medtronic plc - Common Stock (MDT)

Historical Holders from Q1 2014 to Q4 2025

Symbol: MDT on NYSE
Type / Class: Equity / Common Stock
Shares outstanding: 1,282,559,305
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 1,073,629,574
Holdings value: $102,256,630,693
% of all portfolios: 0.09%
Number of holders: 2,138
Number of buys: 1,071
Number of sells: 934
Average buys %: +0.01%
Average sells %: -0.01%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Medtronic plc - Common Stock (MDT) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VANGUARD GROUP INC	10%		$11,837,817,172		130,949,305		The Vanguard Group	28 Nov 2025
BlackRock, Inc.	6.9%		$7,461,254,034		88,655,585		BlackRock, Inc.	31 Mar 2025

As of 30 Sep 2025 Medtronic plc - Common Stock (MDT) has 2,138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,073,629,574 shares of 1,282,559,305 outstanding shares and own 84% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Medtronic plc - Common Stock (MDT) own 53% of the company based on 13F filings as of 30 Sep 2025

Filer	Ownership	Nb Shares	Share Change %	Portfolio %	Holdings Value
VANGUARD GROUP INC	9.9%	127,072,962	+0.13%	0.18%	$12,102,428,902
BlackRock, Inc.	9.3%	119,568,806	-2.4%	0.2%	$11,387,733,085
STATE STREET CORP	4.7%	60,460,537	+1%	0.2%	$5,800,549,521
JPMORGAN CHASE & CO	4.1%	52,195,764	+49%	0.32%	$4,971,126,646
Capital Research Global Investors	2.4%	30,692,989	-16%	0.55%	$2,923,194,833
GEODE CAPITAL MANAGEMENT, LLC	2.2%	27,647,562	-2.1%	0.17%	$2,620,412,217
BANK OF AMERICA CORP /DE/	1.9%	24,247,143	+9.4%	0.17%	$2,309,297,815
Bank of New York Mellon Corp	1.7%	21,468,260	+0.9%	0.37%	$2,044,637,177
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	1.6%	21,086,499	+0.47%	0.62%	$2,008,278,165
MORGAN STANLEY	1.6%	20,232,249	+6.3%	0.12%	$1,926,919,715
DEUTSCHE BANK AG\	1.4%	17,736,697	-6.6%	0.57%	$1,689,243,022
Invesco Ltd.	1.3%	16,204,661	-8.2%	0.24%	$1,543,331,936
ROYAL BANK OF CANADA	1.1%	14,237,196	+28%	0.24%	$1,355,952,000
AMERIPRISE FINANCIAL INC	0.98%	12,534,866	-14%	0.27%	$1,193,934,134
NORTHERN TRUST CORP	0.95%	12,129,386	-0.79%	0.15%	$1,155,202,724
FRANKLIN RESOURCES INC	0.9%	11,492,577	-2.4%	0.27%	$1,094,553,025
RAYMOND JAMES FINANCIAL INC	0.87%	11,203,865	+3%	0.34%	$1,067,054,924
UBS Group AG	0.87%	11,202,878	+96%	0.21%	$1,066,962,101
WELLINGTON MANAGEMENT GROUP LLP	0.79%	10,189,586	+35%	0.17%	$970,456,172
First Eagle Investment Management, LLC	0.76%	9,735,038	+0.03%	1.7%	$927,165,031
Legal & General Group Plc	0.74%	9,483,711	+9.6%	0.2%	$903,228,631
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC	0.67%	8,634,182	-16%	0.18%	$822,319,495
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.64%	8,175,791	+0.19%	0.12%	$778,662,335
GOLDMAN SACHS GROUP INC	0.64%	8,164,720	-54%	0.11%	$777,607,982
ALLIANCEBERNSTEIN L.P.	0.62%	7,921,480	+42%	0.24%	$754,441,755

Institutional Holders of Medtronic plc - Common Stock (MDT) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q4	1,183,947	$113,742,742	-$3,045,068			$96.06	57
2025 Q3	1,073,629,574	$102,256,630,693	-$656,454,813	$579,744,485	$847,758,691	$95.24	2,138
2025 Q2	1,082,710,412	$94,412,733,436	+$1,865,139,448	$772,272,780	$904,830,164	$87.17	2,115
2025 Q1	1,060,189,456	$95,237,696,116	+$125,218,666	$833,712,858	$884,082,291	$89.86	2,137
2024 Q4	1,064,183,008	$85,080,326,911	+$703,263,540	$545,001,086	$518,648,235	$79.88	2,095
2024 Q3	1,048,334,210	$94,383,151,962	-$699,342,905	$642,887,379	$716,615,106	$90.03	2,035
2024 Q2	1,058,327,951	$83,342,475,135	-$2,758,106,144	$343,598,564	$554,952,863	$78.71	1,999
2024 Q1	1,093,749,433	$95,270,041,268	+$387,164,315	$681,361,391	$528,439,281	$87.15	2,048
2023 Q4	1,087,965,051	$89,660,249,885	-$269,861,428	$550,996,123	$557,909,511	$82.38	2,048
2023 Q3	1,090,697,745	$85,465,926,428	+$293,375,202	$373,982,211	$534,865,950	$78.36	1,947
2023 Q2	1,086,574,033	$95,680,614,824	-$385,945,404	$397,172,179	$424,624,749	$88.10	2,029
2023 Q1	1,090,277,471	$87,892,843,380	+$696,533,584	$498,447,030	$570,801,824	$80.62	1,958
2022 Q4	1,082,281,283	$84,167,427,180	-$246,934,545	$439,727,264	$725,915,932	$77.72	1,924
2022 Q3	1,084,715,436	$87,724,015,453	+$1,292,460,429	$401,004,400	$654,112,900	$80.75	1,894
2022 Q2	1,065,231,354	$95,620,261,433	-$180,696,284	$377,193,590	$593,062,280	$89.75	1,975
2022 Q1	1,073,180,822	$119,091,032,435	-$194,091,137	$537,107,895	$884,494,445	$110.95	2,066
2021 Q4	1,075,569,610	$111,347,528,661	-$193,274,037	$832,166,000	$908,690,000	$103.45	2,019
2021 Q3	1,074,115,701	$134,673,451,142	-$643,717,494	$884,807,000	$972,735,750	$125.35	1,981
2021 Q2	1,080,003,441	$134,083,042,145	-$524,988,822	$596,919,200	$816,341,250	$124.13	1,957
2021 Q1	1,083,209,356	$127,976,659,297	+$640,958,996	$598,283,000	$753,366,000	$118.13	1,929
2020 Q4	1,075,833,662	$126,008,600,860	-$139,830,178	$923,906,504	$830,397,532	$117.14	1,907
2020 Q3	1,081,915,335	$112,412,998,502	-$1,213,691,421	$745,735,000	$770,704,000	$103.92	1,771
2020 Q2	1,091,580,345	$100,168,948,058	-$112,204,884	$628,175,180	$577,586,540	$91.70	1,715
2020 Q1	1,093,396,485	$98,660,486,121	-$664,484,689	$460,691,000	$823,434,000	$90.18	1,710
2019 Q4	1,099,875,362	$124,831,623,943	+$1,088,629,181	$702,867,000	$822,701,000	$113.45	1,771
2019 Q3	1,089,396,290	$118,351,693,998	-$342,497,982	$528,798,000	$650,605,000	$108.62	1,601
2019 Q2	1,092,695,517	$106,413,152,178	+$2,258,111,272	$537,100,000	$650,266,000	$97.39	1,572
2019 Q1	1,079,286,822	$98,322,678,939	-$680,264,420	$363,687,000	$341,643,000	$91.08	1,553
2018 Q4	1,087,654,081	$98,967,064,105	-$912,349,694	$528,179,000	$554,255,000	$90.96	1,517
2018 Q3	1,096,831,309	$107,891,802,174	+$2,119,393,406	$631,089,000	$608,818,000	$98.37	1,442
2018 Q2	1,075,722,205	$92,090,921,226	-$1,792,773,789	$437,649,000	$743,521,000	$85.61	1,364
2018 Q1	1,095,654,757	$87,886,197,172	-$226,411,573	$416,760,570	$417,342,430	$80.22	1,333
2017 Q4	1,101,228,648	$88,931,775,379	-$1,124,204,032	$499,484,050	$419,819,250	$80.75	1,353
2017 Q3	1,116,313,005	$86,823,840,096	+$1,179,267,682	$430,028,000	$235,067,000	$77.77	1,234
2017 Q2	1,107,563,057	$98,352,488,805	-$1,230,635,786	$328,351,000	$317,687,000	$88.75	1,226
2017 Q1	1,128,163,040	$90,907,873,262	+$6,407,131,266	$333,444,000	$270,623,000	$80.56	1,225
2016 Q4	1,136,070,757	$80,940,595,889	+$5,430,063,568	$417,259,000	$323,069,000	$71.23	1,210
2016 Q3	1,050,670,429	$90,739,403,183	-$1,834,333,446	$431,744,000	$326,677,000	$86.40	1,195
2016 Q2	1,065,797,423	$92,473,844,125	-$43,846,000	$448,079,000	$384,751,000	$86.77	1,180
2016 Q1	1,064,962,814	$79,867,770,733	-$555,455,029	$290,186,000	$360,363,000	$75.00	1,155
2015 Q4	1,079,297,028	$83,028,254,448	-$1,322,095,259	$260,124,000	$368,189,000	$76.92	1,160
2015 Q3	1,092,906,719	$73,169,912,001	+$839,500,993	$272,867,000	$283,953,000	$66.94	1,106
2015 Q2	1,084,585,344	$80,367,887,165	-$1,011,284,875	$316,419,000	$326,829,000	$74.10	1,144
2015 Q1	1,096,105,576	$85,485,291,199	+$83,549,148,792	$315,522,000	$470,709,000	$77.99	1,080
2014 Q4	24,685,038	$1,782,400,607	+$1,424,749,015	$7,893,000		$72.20	96
2014 Q3	4,575,414	$283,446,000	-$9,430,396			$61.95	8
2014 Q2	4,727,254	$301,410,000	+$290,193,754			$63.76	7
2014 Q1	191,962	$12,028,598	+$824,650			$61.54	8